US April Payrolls Surge Past Expectations Yet Underlying Weaknesses Persist Consumer Resilience Fuels Economic Optimism Amid Persistent Headwinds The Geopolitical Race for NextGeneration Computing Militaries Turn to Experimental Tech Beyond AI QXO Launches Hostile Takeover Bid for Beacon Building Products After Repeated Rejections JK Tyre Q4 Net Profit Surges 80 to Rs 178 Crore Announces Rs 4980 Crore Expansion Plan China Urges APEC Cooperation Amid Commerce Ministers Absence Due to Urgent Official Business Hallador Energy Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Developments MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline OPRX Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance SOHU Q1 2026 Earnings Narrowing Loss Amidst Challenging Conditions Nomura Holdings Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment Kemper Corporation KMPR Declines Nearly 2 Approaching Key Support at 2578 Avient Corporation AVNT Holds Steady Above Support After Modest Gain IonQ IONQ Gains Ground as Quantum Computing Stock Approaches Key Resistance CAMP4 Therapeutics Surges 45 as Biotech Sentiment Improves CAMP Tests Key Resistance Tarsus Pharmaceuticals TARS Faces Resistance at 63 Pulls Back to 60 Support Zone Salesforce CEO Marc Benioff Outlines Turnaround Plan Amid Stock Slump Focus on Products and Buybacks ABT Q1 2026 Earnings Slight EPS Miss Sends Stock Lower as Core Businesses Show Resilience Solana Company HSDT Holds Steady Near Support Eyes Key Resistance First Internet Bancorp INBK Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Interest Income AXTI Q1 2026 Earnings NarrowerthanExpected Loss Drives Sharp Rally AIxCrypto Holdings Inc AIXC Q3 2023 Earnings Significant EPS Beat Despite Ongoing Challenges UMB Financial Corporation UMBFO Q1 2026 Earnings Strong EPS Beat on Solid Operational Performance DLB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Mega Matrix Inc MPU Q3 2023 Earnings Reports Loss Per Share Amid No Revenue Disclosure SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise